Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
TELITHROMYCIN
Ketek
Acute otitis media
EFC6132TELI COMNCT00315003Summary
TELITHROMYCIN
Ketek
Tonsillitis, Pharyngitis
EFC6133TELI TONNCT00315042Summary
TELITHROMYCIN
Ketek
Tonsillitis, Pharyngitis
EFC6134TELI TADNCT00315549Summary
TELITHROMYCIN
Ketek
Pneumonia, Community-Acquired
EFC6369 (HMR 3647B/3101)NANCT00638859Summary
TELITHROMYCIN
Ketek
Otitis Media, Acute
EFC6370 (HMR 3647B/3103)NANCT00638534Summary
TELITHROMYCIN
Ketek
Infection
EFC6371 (HMR 3647B/3104)NANCT00408135Summary
TELITHROMYCIN
Ketek
Asthma
HMR3647A_3503TELICASTNCT00273520Summary
TELITHROMYCIN
Ketek
Infection
HMR3647A_4014STROBENCT00538148Summary
TELITHROMYCIN
Ketek
Infection
HMR3647A_4015COBRANCT00538018Summary
TELITHROMYCIN
Ketek
Infection
HMR3647A_4017NANCT00537563Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted